Log in

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 [29] 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55
  1. Smoking, diets rich in animal products, alcohol have correlations with cancer inciden (2 replies)
  2. Cancer immunotherapy named 2013 Breakthrough of the Year by journal Science (0 replies)
  3. FNIH Biomarkers Consortium announces initial results of I-SPY 2 trial for breast canc (0 replies)
  4. Cells' adaptations to low oxygen conditions inside tumors promote breast cancer's spr (0 replies)
  5. Market research report on injectable generic and biosimilar drugs (0 replies)
  6. Researchers complete genomic analysis of cervical cancer in two patient populations (0 replies)
  7. Younger women with breast cancer less likely to receive radiotherapy after BCS (0 replies)
  8. Racial divide for breast cancer survival widens (0 replies)
  9. Acupuncture treatments may help alleviate side effects of breast cancer drugs (0 replies)
  10. First Edition: December 23, 2013 (0 replies)
  11. Breast cancer patients experience fewer side effects on using aromatase inhibitor wit (0 replies)
  12. Real and sham weekly acupuncture treatments ease hot flashes of anticancer drug treat (0 replies)
  13. Poll finds very mixed views on morning-after pill; black/white breast cancer disparit (0 replies)
  14. Researchers start first cancer operation room with navigator (0 replies)
  15. Tomato-rich diet may help lower breast cancer risk in postmenopausal women (0 replies)
  16. Periodic meetings with lactation consultant improves chances of breastfeeding (0 replies)
  17. First Edition: December 20, 2013 (0 replies)
  18. Joint initiative aims to eradicate health disparities among communities of color in t (0 replies)
  19. New research assesses nanomedicine-based approaches for treating cancer (0 replies)
  20. Some Americans reflect on insurance they had pre-health law (0 replies)
  21. Royal Philips gets FDA approval for Spectral Breast Density Measurement Application (0 replies)
  22. Computer-controlled, rotating table deliver high doses of radiotherapy to tumors spar (0 replies)
  23. New study aims to identify breast cancer patients most susceptible to post-treatment (0 replies)
  24. Alexandria-based Prevent Cancer Foundation gets $5,000 grant from Cardinal Bank Commu (0 replies)
  25. Aerobic glycolysis is a cause of malignancy, show Berkeley Lab researchers (0 replies)
  26. Scientists back ovarian cancer preventative surgery to improve survival (0 replies)
  27. UCLA scientists receive $21M grant to conduct groundbreaking clinical trials on stem (0 replies)
  28. Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection (0 replies)
  29. Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors (1 replies)
  30. Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leuke (0 replies)
  31. New report shows death rates for lung cancer dropping at a faster pace (0 replies)
  32. PAM50 FDA-cleared breast cancer test to be launched at ARUP Laboratories (0 replies)
  33. Switching chemotherapy does not improve survival in metastatic breast cancer patients (0 replies)
  34. Adding drug to presurgery chemotherapy improves results for women with triple-negativ (0 replies)
  35. Combination of ramucirumab and docetaxel fails to delay advanced breast cancer progre (0 replies)
  36. Study could lead towards a personalised medicine for chemoresistant lymphomata (0 replies)
  37. New technologies unveiled to provide expert care and streamline the process of treati (0 replies)
  38. Bisphosphonate zoledronate treatment not effective in women with chemoresistant breas (0 replies)
  39. Researchers test promising new breast cancer drugs (1 replies)
  40. Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signa (0 replies)
  41. Deep genome sequencing used to predict clinical outcomes in patients with breast canc (0 replies)
  42. Anastrozole drug reduces breast cancer in high risk post-menopausal women (0 replies)
  43. Research shows that deep sequencing of breast cancer tumors predicts future outcomes (0 replies)
  44. VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advan (0 replies)
  45. New mutations in the estrogen receptor drive strong drug resistance exhibited by huma (0 replies)
  46. Genomic tests help in selecting the most effective therapy for breast cancer (0 replies)
  47. Dasatinib+letrozole improves survival for women with hormone receptor-positive, HER2- (0 replies)
  48. Researchers discover completely new targets for treatment of blood cancers (0 replies)
  49. Breast cancer survivors taking AIs may experience reduction in joint pain on exercisi (0 replies)
  50. Over-use of staging procedures more prevalent in younger, early-stage breast cancer p (0 replies)
  51. Scientists bring stem cell science directly to patients (0 replies)
  52. Women treated with breast cancer drugs can ease joint pain by engaging in exercise (0 replies)
  53. Researchers find way to stop first part of breast cancer metastasis in mice (0 replies)
  54. More outreach needed for family members who carry genetic risks of cancer (0 replies)
  55. Z-endoxifen may provide better treatment for women with estrogen positive breast canc (0 replies)
  56. Anastrozole drug: An effective new option for breast cancer prevention for postmenopa (0 replies)
  57. Allianz Worldwide Care's standard plans now include extended healthcare coverage (0 replies)
  58. Results from NeoALTTO trial to be presented at 2013 San Antonio Breast Cancer Symposi (1 replies)
  59. Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients (0 replies)
  60. Infants likely becoming exposed to potentially harmful substances via PCPs (0 replies)
  61. New mechanism explains why anti-tumor activity of specific immune suppressed during t (0 replies)
  62. HSET protein could help doctors identify aggressive breast cancers in African-America (0 replies)
  63. Tumor-infiltrating lymphocytes may be good biomarker of response to trastuzumab in br (0 replies)
  64. New test to help physicians identify patients with most lethal forms of triple-negati (0 replies)
  65. New study may pave way for more effective treatment for deadly childhood cancer (0 replies)
  66. Women with HER2+ breast tumors who receive combination therapy unlikely to have cance (0 replies)
  67. Romidepsin drug shows surprising benefit in preclinical studies of inflammatory breas (0 replies)
  68. New drug combination therapy effective for patients with HER2-positive breast cancer (0 replies)
  69. PROMISING-Three Powerhouses Team Up To Form Juno (0 replies)
  70. Motivated forgetting often occurs when people feel the most threatened, says study (0 replies)
  71. High cholesterol fuels growth and spread of breast Cancer (0 replies)
  72. Navidea receives Fast Track designation for Lymphoseek injection (0 replies)
  73. Nanostring Technologies announces nationwide availability of Prosigna Breast Cancer A (0 replies)
  74. Immunologists receive $4.8M grant to target multiple diseases by manipulating enzyme (0 replies)
  75. First Edition: December 10, 2103 (0 replies)
  76. Researchers explains why anti-tumor activity of specific immune cells suppressed duri (2 replies)
  77. Exercise can improve musculoskeletal health for breast cancer survivors, say research (0 replies)
  78. Scientists' targeted protein-detection approach has potential to measure entire human (0 replies)
  79. Low-income women less likely to receive breast cancer treatment (0 replies)
  80. Increased levels of protein HSET linked with worse breast cancer outcomes in African- (0 replies)
  81. UCSF awarded $9.45M federal grant to transform, revolutionize treatment of prostate c (0 replies)
  82. Scientists target protein-detection approach to systematically measure human repertoi (0 replies)
  83. Cancer survival rates still vary widely between European countries (0 replies)
  84. State highlights: S.C. Medicaid director touts lower spending; La. targets docs who s (0 replies)
  85. Ventana now offers FDA-cleared image analysis and digital read application for IHC br (0 replies)
  86. Evidence reveals lack of public acceptance toward breast-feeding may influence hesita (0 replies)
  87. Archimedes Model simulation suggests genetic screening for breast cancer risk can red (0 replies)
  88. Lung cancer is costliest cancer in European Union (0 replies)
  89. Smoking and obesity increase odds of early breast implant loss (0 replies)
  90. MR-guided ultrasound may offer safe and effective treatment for breast cancer (0 replies)
  91. 18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with bra (0 replies)
  92. Frequent mammography screening reduces the rate of lymph node positivity (0 replies)
  93. Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums (3 replies)
  94. CTCs serve as clinical tool to determine patient’s response to chemotherapy (0 replies)
  95. Study shows that DBT increases cancer detection, reduces recall rates (0 replies)
  96. Automated breast density measurement predicts breast cancer risk in younger women (0 replies)
  97. Digital breast tomosynthesis reduces recall rates and increases cancer detection (0 replies)
  98. Reimbursement cuts for image-guided breast biopsies may reduce women's access to mamm (0 replies)
  99. 3D mammography identifies 22% more breast cancers than traditional mammography (0 replies)
  100. Researchers create computer algorithm to identify specific genes involved in breast c (0 replies)
  101. Special issue of JACR focuses on the role of imaging-based screening in preventive me (0 replies)
  102. GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013 (0 replies)
  103. Cyclin D1 protein controls cell cycle progression, microRNA biogenesis in breast canc (0 replies)
  104. Elevated cholesterol is associated with breast cancer risk (0 replies)
  105. Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies (0 replies)
  106. Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying ma (0 replies)
  107. Researchers show benefits from testosterone administration in hysterectomized women (0 replies)
  108. Viewpoints: Local political fallout from Obama insurance pledge; 'debunking' sob stor (0 replies)
  109. Women who test negative for family-specific BRCA2 mutations may have four times risk (0 replies)
  110. FDA orders halt to marketing for DNA test kit (0 replies)
  111. High-fat food consumption during puberty may increase the risk of breast cancer (0 replies)
  112. Researcher receives $225,000 grant to study epigenetic changes associated with chemot (0 replies)
  113. Researchers reveal why some breast cancer cells are resistant to chemotherapy (0 replies)
  114. Biocon receives regulatory approval for biosimilar product, trastuzumab (0 replies)
  115. CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastati (0 replies)
  116. Super cocktail of six natural compounds killed 100% of breast cancer cells without to (0 replies)
  117. Hologic to highlight groundbreaking imaging products at RSNA 2013 (0 replies)
  118. Findings show how cancer and aging are tightly interconnected (0 replies)
  119. ORC to develop paper-based sensors that can be used to detect biomarkers in cancer pa (0 replies)
  120. Viewpoints: Obamacare has resisted death throes before; website success stories from (0 replies)
  121. Manipulating PRH protein can help prevent cancer cells from unnecessary migration (0 replies)
  122. Obese women face increased risk of developing aggressive sub-type of breast cancer (0 replies)
  123. Mutations affecting immune system play important role in breast cancer (0 replies)
  124. Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vaccine (1 replies)
  125. Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East (0 replies)
  126. Study shows chronic diseases have strong negative impact on cancer survival rate (0 replies)
  127. MD Anderson Cancer Center Orlando receives national accreditation for treatment of br (0 replies)
  128. ESBC joins with Athena Breast Health Network to advance personalized breast cancer ri (0 replies)
  129. ETPN and NANOMED 2020 honor Endomagnetics with Nanomedicine Award (0 replies)
  130. Early detection of breast cancer could soon be possible with blood test (0 replies)
  131. Cells sticking molecule over-produced in rheumatoid arthritis and cancers (0 replies)
  132. Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breas (0 replies)
  133. Research reveals unexpected roles that sex hormones may play in cognitive function (0 replies)
  134. Targeted radiotherapy could offer viable alternative to current procedures for breast (0 replies)
  135. Nutranomics provides update on GenEpic prostate cancer human clinical study (0 replies)
  136. Financially less women more likely to delay seeking medical attention for breast canc (0 replies)
  137. Researchers reveal that reduction in mitochondrial DNA may lead to metastasis of brea (0 replies)
  138. Breast cancer drug appears to protect cells against UV radiation, inflammation (0 replies)
  139. Report: Postmastectomy pain rated as most troubling symptom by breast cancer survivor (0 replies)
  140. Viewpoints: The battle over one woman's medical story; why Mass. didn't see a wave of (0 replies)
  141. Researchers discover cholesterol metabolite promotes tumor growth in breast cancers (0 replies)
  142. Nanoparticles with chemotherapeutic drugs can kill drug-resistant breast cancer cells (0 replies)
  143. Researchers identify enzymes that are crucial for growth of cancers with genetic aber (0 replies)
  144. MU researchers find more accurate laboratory method for diagnosing pancreatic cancer (0 replies)
  145. AMGA honors Mid-Atlantic Permanente Medical Group with Acclaim Award (0 replies)
  146. Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlan (0 replies)
  147. Researchers use machine learning approach to accurately diagnose breast cancer (0 replies)
  148. The Princess Margaret Cancer Foundation launches innovative Fall advertising campaign (1 replies)
  149. Trial in Japan to destroy breast tumors by freezing. (0 replies)
  150. Nanomedicine Award winners were officially announced at BIO-Europe conference (0 replies)
  151. Gene sequencing reveals mutations in estrogen receptor (0 replies)
  152. Obesity is largest predictor of earlier onset puberty in girls, shows research (0 replies)
  153. IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients (0 replies)
  154. Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014 (0 replies)
  155. Eliza's Star multi-modal programs address gaps in healthcare (0 replies)
  156. Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma su (0 replies)
  157. Unrealistic pessimists less likely to take preventive action after receiving good new (0 replies)
  158. Study finds links between breast cancer radiation and long-term cardiovascular-relate (0 replies)
  159. Study reveals that specific protein may assist breast cancer cells in metastasizing (0 replies)
  160. Self-directed walking program shows promise in easing joint stiffness in older breast (0 replies)
  161. McGill online game expands to connect global scientific community with citizen scient (1 replies)
  162. MIT researchers design stealth drug delivery system to attack TNBC cells (0 replies)
  163. Diabetic patients may require higher doses of metformin to achieve same anti-cancer a (0 replies)
  164. "One-two punch" disables tumors' defenses (0 replies)
  165. ProMedica Toledo Hospital now has new tool to help evaluate breast tissue density on (0 replies)
  166. New report explains occurrence of breast cancer in women with normal BRCA genes (0 replies)
  167. Scientists identify link between rare mutations in RINT1 gene and early onset breast (0 replies)
  168. New Centre for Stratified Medicine opened in Ireland (0 replies)
  169. Patient assistance programs help breast cancer patients to learn more about adjuvant (1 replies)
  170. Nanometric scale diamond particles offer new way to detect cancer far earlier (0 replies)
  171. New imaging tool could someday be used for routine breast cancer screenings (0 replies)
  172. A simple blood test may reveal the earliest signs of pancreatic cancer (0 replies)
  173. Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II (0 replies)
  174. New PARP inhibitor shows early responses in patients with advanced BRCA-related cance (0 replies)
  175. Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients wi (0 replies)
  176. BRCA1/2 mutations may alter endometrial, ovarian function (0 replies)
  177. Risk for breast cancer: Key prevention awareness tips for young women (0 replies)
  178. Sleep anomalies not linked to breast cancer incidence (0 replies)
  179. Verastem presents positive results from VS-6063 clinical and preclinical studies at 2 (0 replies)
  180. UCLA study uncovers biological clock that may shed light on why our bodies age (0 replies)
  181. EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer (0 replies)
  182. Bioengineers build novel tool to visualize protein networks from breast cancer cell d (0 replies)
  183. New investigational drug offers potential treatment option for lung cancer patients (0 replies)
  184. New small-molecule inhibitor shows promising results in drug-resistant melanoma, brea (0 replies)
  185. New research identifies internal timepiece that accurately gauge age of human organs (0 replies)
  186. Research: Hypermutation in cancer is more frequent in inactive X chromosome (0 replies)
  187. Eye Am Empowered: A social media support network for women experiencing life challeng (0 replies)
  188. Women diagnosed with breast cancer are 39% more likely to develop second cancer (0 replies)
  189. Good news: Knowing risk early, women can take action to prevent osteoporosis (0 replies)
  190. Scientists identify 127 mutated genes that appear to drive development of tumors in t (0 replies)
  191. Researchers discover why women with BRCA gene develop breast and ovarian cancer (0 replies)
  192. New England publishes results of phase III clinical trial of ABRAXANE for metastatic (0 replies)
  193. Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in m (0 replies)
  194. Breast cancer patients receiving nerve block with general anesthesia have less cancer (0 replies)
  195. University of Sydney's free public talk to focus on halting superbug apocalypse (0 replies)
  196. Study evaluates economic cost of cancer across 27 countries of the EU (0 replies)
  197. Results announced for Phase II PRECEDENT trial of vintafolide in treatment of platinu (0 replies)
  198. New optical imaging technique can accurately differentiate breast cancer subtypes (0 replies)
  199. Researchers create online database of disease genes that could be targeted with drugs (0 replies)
  200. Non-hormonal chronic pain treatment reduces moderate-to-severe hot flashes (0 replies)
  201. Novartis Inks Agreement For Immunogen's "TAP" ADC Technology (0 replies)
  202. Novartis Inks Agreement For Immunogen's "TAP" ADC Technology (1 replies)
  203. Report provides new estimates of breast cancer rates among active component service w (0 replies)
  204. Charles J. Sherr to receive Prize for Scientific Excellence in Medicine (0 replies)
  205. New report provides solutions for fracture prevention, management for postmenopausal (0 replies)
  206. Researcher receives grant to explore HER2-positive breast tumor susceptibility to PAR (0 replies)
  207. High levels of HDL have been linked to increased breast cancer risks, enhance cancer (0 replies)
  208. Risk of dying from invasive breast cancer lower among multivitamin/mineral users (0 replies)
  209. HMI, NCONN to collaborate on various educational initiatives for oncology health prof (0 replies)
  210. Delivering more personalized care for breast cancer patients (0 replies)
  211. Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutatio (0 replies)
  212. Sahlgrenska Academy study finds no traces of viruses in breast cancer and glioblastom (0 replies)
  213. Depression impairs sleep in breast cancer, but being married helps (0 replies)
  214. Clinical study to determine sentinel lymph node surgery in patients with breast cance (0 replies)
  215. UNM School of Medicine recruited two new hires for Department of Surgery (0 replies)
  216. Less-invasive procedure identifies cancer remains in lymph nodes after chemotherapy (0 replies)
  217. Scientists devised technique to make antibody-drug conjugates, basis of new therapies (0 replies)
  218. Eddingpharm Secures Immutep’S Immufact IMP321 For Growing Stable (0 replies)
  219. Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321 (0 replies)
  220. Eddingpharm Adds Immutep’S Immufact IMP321 To Growing Stable (0 replies)
  221. Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS (0 replies)
  222. Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson (0 replies)
  223. Research roundup: Health law's effects on consumer spending; Mass. experience finds i (0 replies)
  224. New biomarker for pancreatic cancer effectively targets potential therapy for small s (0 replies)
  225. Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting (0 replies)
  226. New technique for breast cancer treatment and prevention-injection via nipple (0 replies)
  227. Study: Physical activity reduces risk of breast cancer in postmenopausal women (0 replies)
  228. Cynvenio launches ClearID Breast Cancer monitoring program (0 replies)
  229. Walking an hour per day associated with lower risk of breast cancer in women (0 replies)
  230. Lilly Peers Into Future, Sees Three Drug Launches In 2014 (0 replies)
  231. New method to monitor activity of gene promoters during response to drug (0 replies)
  232. Data analyses from Brisdelle Phase 3 pivotal trials to be showcased at NAMS' meeting (0 replies)
  233. Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval (1 replies)
  234. Genetic discovery could take guesswork out of prescribing correct dose of drugs (0 replies)
  235. Nia exercise benefits individuals with breast cancer (0 replies)
  236. FDA grants accelerated approval of Perjeta for people with HER2-positive early stage (0 replies)
  237. Women of Mexican descent more likely to be diagnosed with aggressive form of breast c (0 replies)
  238. Breast cancer incidence rates increasing among African Americans; reasons unclear (0 replies)
  239. Research reveals significant role of Axl receptor in progression, therapeutic resista (0 replies)
  240. FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer (0 replies)
  241. Report: More Hispanic Texans die from cancer than any other cause (0 replies)
  242. Liquid biopsy: New device could help doctors diagnose and treat cancers (0 replies)
  243. Study shows prevalence of PTSD responses in female patients after cancer treatment (0 replies)
  244. Stem cell-enriched fat grafting may prove an attractive option to major tissue augmen (0 replies)
  245. Health expenditure link to cancer survival in Europe (0 replies)
  246. Diabetic patients at greater risk of breast, colon cancer (0 replies)
  247. Colorectal cancer screening in European countries highly effective in reducing mortal (0 replies)
  248. Researchers develop new breast cancer screening technique that can reduce false posit (0 replies)
  249. SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy (0 replies)
  250. Mayo Clinic experts to discuss risk factors, screening and treatments for breast canc (0 replies)